Apoptosis and cancer therapy : from cutting-edge science to novel therapeutic concepts |
Pubbl/distr/stampa | [Place of publication not identified], : Wiley VCH, 2006 |
Disciplina | 616.99407 |
Soggetto topico |
Apoptosis - Regulation - Growth
Cellular signal transduction - Treatment Tumors Cancer Apoptosis Gene Expression Regulation, Neoplastic Signal Transduction Neoplasms - therapy Cytology Biology Health & Biological Sciences |
ISBN | 3-527-61966-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910677185803321 |
[Place of publication not identified], : Wiley VCH, 2006 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Artificial Intelligence and Precision Oncology [[electronic resource] ] : Bridging Cancer Research and Clinical Decision Support / / edited by Zodwa Dlamini |
Edizione | [1st ed. 2023.] |
Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023 |
Descrizione fisica | 1 online resource (317 pages) |
Disciplina | 610.28563 |
Soggetto topico |
Cancer
Oncology Medical screening Cancer—Treatment Tumor markers Artificial Intelligence Precision Medicine Neoplasms - therapy Epigenomics Drug Design Biomarkers, Tumor Cancer Biology Cancer Screening Cancer Therapy Tumour Biomarkers |
ISBN |
9783031215063
9783031215056 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Chapter 1. Introduction: The Application of AI in Precision Oncology: Tailoring Diagnosis, Treatment, and the Monitoring of Disease Progression to the Patient -- Part I. Artificial Intelligence for Screening, Diagnosis, Monitoring in Precision Oncology -- Chapter 2. Application of AI in Novel Biomarkers Detection that Induce Drug Resistance, Enhance Treatment Regimens and Advancing Precision Oncology -- Chapter 3. Use of Artificial Intelligence in Implementing Mainstream Precision Medicine to Improve Traditional Symptom-driven Practice of Medicine: Allowing Early Interventions and Tailoring better-personalized Cancer Treatments -- Chapter 4. AI as a Novel Approach for Exploring ccfNAs in Personalized Clinical Diagnosis and Prognosis: Providing Insight into the Decision-Making in Precision Oncology -- Chapter 5. AI-Enhanced Digital Pathology and Radiogenomics in Precision Oncology -- Part II. Artificial Intelligence and Omics in Precision Oncology -- Chapter 6. Epigenetics Analysis Using Artificial Intelligence in the Era of Precision Oncology -- Chapter 7. Association of Metabolomics with AI in Precision Oncology: Emerging Perspectives for More Effective Cancer Care -- Chapter 8. Artificial Intelligence Application to Microbiomics Data for Improved Clinical Decision Making in Precision Oncology -- Part III. Artificial Intelligence in Cancer Therapy and the Clinical Applications -- Chapter 9. AI and Nanotechnology in Realizing the Goal of Precision Medicine: Tailoring the Best Treatment for Personalized Cancer Treatment -- Chapter 10. Artificial Intelligence-Based Medical Devices Revolution in Cancer Screening: Impact into Clinical Practice -- Chapter 11. Intelligent Drug Design and Use for Cancer Treatment: The Roles of AI and Precision Oncology in Targeting Patient-Specific Splicing Profiles -- Chapter 12. Applying Artificial Intelligence Prediction Tools for Advancing Precision Oncology in Immunotherapy: Future Perspectives in Personalized Care -- Chapter 13. Employing AI-Powered Decision Support Systems in Recommending the Most Effective Therapeutic Approaches for Individual Cancer Patients: Maximizing Therapeutic Efficacy -- Chapter 14. AI-Pathway Companion in Clinical Decision Support: Enabling Personalized and Standardized Care Along Care Pathways in Oncology -- Chapter 15. AI Tools Offering Cancer Clinical Applications for Risk Predictor, Early Detection, Diagnosis, and Accurate Prognosis: Perspectives in Personalised Care -- Chapter 16. Conclusion and Insights into the Future of AI in Precision Oncology. |
Record Nr. | UNINA-9910739486103321 |
Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Artificial intelligence based cancer nanomedicine : diagnostics, therapeutics and bioethics / / edited by Fahima Dilnawaz and Ajit Kumar Behura |
Edizione | [First edition.] |
Pubbl/distr/stampa | Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022] |
Descrizione fisica | 1 online resource (110 pages) : illustrations |
Disciplina | 610.285 |
Soggetto topico |
Artificial intelligence - Medical applications
Cancer - Treatment Drug delivery systems Nanomedicine Bioethical Issues Artificial Intelligence Neoplasms - therapy |
ISBN | 981-5050-56-7 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- The Need for Artificial Intelligence in Cancer Nanomedicine -- Fahima Dilnawaz1,* -- INTRODUCTION -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Application of Artificial Intelligence for Designing Cancer Nanomedicine -- Fahima Dilnawaz1,* -- INTRODUCTION -- USE OF NANOMATERIALS AND AI IN PRECISION DIAGNOSTICS -- PREDICTION OF PERSONALIZED DRUG POTENCY BY NANOTECHNOLOGY -- UTILIZING COMPUTATIONAL MODELLING IN NANOTHERAPEUTICS FOR TARGETING AND PERSONALIZED DOSING -- UTILIZING AI AND NANOMATERIALS FOR DRUG DOSING AND IMPROVED THERAPEUTIC EFFICACY -- EXPLOITING THE USE OF AI AND NANOTECHNOLOGY FOR PERSONALIZED GENE THERAPY -- CONCLUSION AND FUTURE PERSPECTIVE -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence and its Application in Cancer Nanomedicine -- Sweta Mohanty1, Sarbari Acharya1 and Chandana Mohanty1,* -- INTRODUCTION -- CANCER NANOMEDICINE -- ARTIFICIAL INTELLIGENCE (AI) -- ROLE OF AI IN DRUG DISCOVERY -- APPLICATION OF AI TECHNOLOGIES IN CANCER NANOMEDICINE -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence-based Diagnostic Design for Precision Cancer Nanomedicine -- Ranjita Misra1,* and Malathi Sampath2 -- INTRODUCTION -- ROLE OF NANOMEDICINES IN CANCER DIAGNOSIS -- NANOMEDICINES USED FOR CANCER DIAGNOSIS -- ARTIFICIAL INTELLIGENCE AND ITS SIGNIFICANCE -- APPLICATION OF ARTIFICIAL INTELLIGENCE TOWARDS CANCER DIAGNOSIS -- ADVANTAGE OF INTEGRATION OF ARTIFICIAL INTELLIGENCE AND NANOMEDICINES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES.
Artificial Intelligence-based Nanosensors to Compose the Patient's Cancer Biomarker Profile -- Malathi Sampath1 and Ranjita Misra2,* -- INTRODUCTION -- NANOSENSORS AND THEIR ROLE IN BIOMARKERS PROFILING -- TYPES OF NANOSENSORS -- Affinity Based Biosensors -- Catalytic Based Sensors -- Enzymes -- Microbes -- Organelles -- Tissue Samples -- OPTICAL NANOSENSORS -- ELECTROCHEMICAL SENSORS -- CHEMICAL NANOSENSORS -- DEPLOYABLE SENSOR -- ELECTROMETERS -- BIOSENSOR -- ADVANTAGES OF AMALGAMATION OF NANOSENSORS WITH ARTIFICIAL INTELLIGENCE -- FUTURE PERSPECTIVES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence as a Putative Tool for Newer Drug Development Approach in Cancer Nanomedicine -- Pooja Jain1, Sradhanjali Mohapatra1, Nazia Hassan1, Manvi Singh2, Uzma Farooq1, Mohd. Aamir Mirza1 and Zeenat Iqbal1,* -- INTRODUCTION -- CANCER -- Cancer Diagnosis and Treatment Approaches -- Cancer Nanomedicines -- ARTIFICIAL INTELLIGENCE -- Integration of AI and Nanotechnology for Cancer Therapy -- Artificial Intelligence-Driven Approach for Future Healthcare System -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGMENT -- REFERENCES -- Artificial Intelligence-Enabled Model for Predicting the Metastatic Potential of Cancer Cells -- Sarbari Acharya1,* and Chandana Mohanty1 -- INTRODUCTION -- CANCER METASTASIS -- DIAGNOSIS OF CANCER METASTASIS -- ARTIFICIAL INTELLIGENCE AND CANCER DETECTION -- ROLE OF AI MODELS FOR PREDICTING CANCER METASTASIS -- FUTURE PERSPECTIVES AND CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence for Cancer Nanotheranostics -- Sarbari Acharya1,* -- INTRODUCTION -- CANCER IMAGING -- THERANOSTICS AND NANOTHERANOSTICS -- ROLE OF NANOTHERANOSTICS IN CANCER MANAGEMENT. AI IN NANOMEDICINE FOR CANCER THERAPY -- AI AND NANOTHERANOSTICS -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Ethical Dimensions of Using Artificial Intelligence in Healthcare -- Ajit Kumar Behura1,* -- INTRODUCTION -- ETHICAL CONSIDERATIONS WHEN USING AI IN HEALTH CARE -- CONCLUSIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index -- Back Cover. |
Record Nr. | UNINA-9910795739803321 |
Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Artificial intelligence based cancer nanomedicine : diagnostics, therapeutics and bioethics / / edited by Fahima Dilnawaz and Ajit Kumar Behura |
Edizione | [First edition.] |
Pubbl/distr/stampa | Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022] |
Descrizione fisica | 1 online resource (110 pages) : illustrations |
Disciplina | 610.285 |
Soggetto topico |
Artificial intelligence - Medical applications
Cancer - Treatment Drug delivery systems Nanomedicine Bioethical Issues Artificial Intelligence Neoplasms - therapy |
ISBN | 981-5050-56-7 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- The Need for Artificial Intelligence in Cancer Nanomedicine -- Fahima Dilnawaz1,* -- INTRODUCTION -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Application of Artificial Intelligence for Designing Cancer Nanomedicine -- Fahima Dilnawaz1,* -- INTRODUCTION -- USE OF NANOMATERIALS AND AI IN PRECISION DIAGNOSTICS -- PREDICTION OF PERSONALIZED DRUG POTENCY BY NANOTECHNOLOGY -- UTILIZING COMPUTATIONAL MODELLING IN NANOTHERAPEUTICS FOR TARGETING AND PERSONALIZED DOSING -- UTILIZING AI AND NANOMATERIALS FOR DRUG DOSING AND IMPROVED THERAPEUTIC EFFICACY -- EXPLOITING THE USE OF AI AND NANOTECHNOLOGY FOR PERSONALIZED GENE THERAPY -- CONCLUSION AND FUTURE PERSPECTIVE -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence and its Application in Cancer Nanomedicine -- Sweta Mohanty1, Sarbari Acharya1 and Chandana Mohanty1,* -- INTRODUCTION -- CANCER NANOMEDICINE -- ARTIFICIAL INTELLIGENCE (AI) -- ROLE OF AI IN DRUG DISCOVERY -- APPLICATION OF AI TECHNOLOGIES IN CANCER NANOMEDICINE -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence-based Diagnostic Design for Precision Cancer Nanomedicine -- Ranjita Misra1,* and Malathi Sampath2 -- INTRODUCTION -- ROLE OF NANOMEDICINES IN CANCER DIAGNOSIS -- NANOMEDICINES USED FOR CANCER DIAGNOSIS -- ARTIFICIAL INTELLIGENCE AND ITS SIGNIFICANCE -- APPLICATION OF ARTIFICIAL INTELLIGENCE TOWARDS CANCER DIAGNOSIS -- ADVANTAGE OF INTEGRATION OF ARTIFICIAL INTELLIGENCE AND NANOMEDICINES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES.
Artificial Intelligence-based Nanosensors to Compose the Patient's Cancer Biomarker Profile -- Malathi Sampath1 and Ranjita Misra2,* -- INTRODUCTION -- NANOSENSORS AND THEIR ROLE IN BIOMARKERS PROFILING -- TYPES OF NANOSENSORS -- Affinity Based Biosensors -- Catalytic Based Sensors -- Enzymes -- Microbes -- Organelles -- Tissue Samples -- OPTICAL NANOSENSORS -- ELECTROCHEMICAL SENSORS -- CHEMICAL NANOSENSORS -- DEPLOYABLE SENSOR -- ELECTROMETERS -- BIOSENSOR -- ADVANTAGES OF AMALGAMATION OF NANOSENSORS WITH ARTIFICIAL INTELLIGENCE -- FUTURE PERSPECTIVES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence as a Putative Tool for Newer Drug Development Approach in Cancer Nanomedicine -- Pooja Jain1, Sradhanjali Mohapatra1, Nazia Hassan1, Manvi Singh2, Uzma Farooq1, Mohd. Aamir Mirza1 and Zeenat Iqbal1,* -- INTRODUCTION -- CANCER -- Cancer Diagnosis and Treatment Approaches -- Cancer Nanomedicines -- ARTIFICIAL INTELLIGENCE -- Integration of AI and Nanotechnology for Cancer Therapy -- Artificial Intelligence-Driven Approach for Future Healthcare System -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGMENT -- REFERENCES -- Artificial Intelligence-Enabled Model for Predicting the Metastatic Potential of Cancer Cells -- Sarbari Acharya1,* and Chandana Mohanty1 -- INTRODUCTION -- CANCER METASTASIS -- DIAGNOSIS OF CANCER METASTASIS -- ARTIFICIAL INTELLIGENCE AND CANCER DETECTION -- ROLE OF AI MODELS FOR PREDICTING CANCER METASTASIS -- FUTURE PERSPECTIVES AND CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence for Cancer Nanotheranostics -- Sarbari Acharya1,* -- INTRODUCTION -- CANCER IMAGING -- THERANOSTICS AND NANOTHERANOSTICS -- ROLE OF NANOTHERANOSTICS IN CANCER MANAGEMENT. AI IN NANOMEDICINE FOR CANCER THERAPY -- AI AND NANOTHERANOSTICS -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Ethical Dimensions of Using Artificial Intelligence in Healthcare -- Ajit Kumar Behura1,* -- INTRODUCTION -- ETHICAL CONSIDERATIONS WHEN USING AI IN HEALTH CARE -- CONCLUSIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index -- Back Cover. |
Record Nr. | UNINA-9910820624103321 |
Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Asian journal of oncology |
Pubbl/distr/stampa | [Mumbai, India], : Wolters Kluwer - Medknow, 2015- |
Descrizione fisica | 1 online resource |
Soggetto topico |
Oncology
Medical Oncology Neoplasms - therapy |
Soggetto genere / forma |
Periodical
Periodicals. |
Soggetto non controllato | Oncology |
ISSN | 2455-4618 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996321738803316 |
[Mumbai, India], : Wolters Kluwer - Medknow, 2015- | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Asian journal of oncology |
Pubbl/distr/stampa | [Mumbai, India], : Wolters Kluwer - Medknow, 2015- |
Descrizione fisica | 1 online resource |
Soggetto topico |
Oncology
Medical Oncology Neoplasms - therapy |
Soggetto genere / forma |
Periodical
Periodicals. |
Soggetto non controllato | Oncology |
ISSN | 2455-4618 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910161657303321 |
[Mumbai, India], : Wolters Kluwer - Medknow, 2015- | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Assessing and improving value in cancer care [[electronic resource] ] : workshop summary / / Adam Schickedanz, rapporteur ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
Pubbl/distr/stampa | Washington, D.C., : National Academies Press, c2009 |
Descrizione fisica | 1 online resource (165 p.) |
Disciplina | 616.994 |
Altri autori (Persone) | SchickedanzAdam |
Soggetto topico |
Cancer - Patients - Medical care
Cancer - Treatment - Economic aspects Cancer Neoplasms - therapy Neoplasms - economics Outcome Assessment, Health Care - economics |
Soggetto genere / forma |
Congress.
Electronic books. |
ISBN |
1-282-43722-4
9786612437229 0-309-13815-9 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
""Front Matter""; ""Reviewers""; ""Contents""; ""Preface""; ""1 Introduction""; ""2 Opening Remarks: What Is Value in Cancer Care and Why Is It Important?""; ""PART I: Challenges to Value in Cancer Care""; ""3 Clinician Patient Communication and Its Influence on Value""; ""4 Generating Evidence About Effectiveness and Value""; ""5 Value and the Oncology Market""; ""6 Value in Oncology Practice: Oncologist and Health Insurer Perspectives""; ""7 Ethical Issues and Value in Oncology""; ""PART II:Solutions for Value in Cancer Care""; ""8 Improving Value in Oncology Practice: Ways Forward""
""9 Toward a Shared Understanding of Value""""Acronyms""; ""Glossary""; ""Appendix A: Workshop Agenda""; ""Appendix B: Speaker and Moderator Biographies"" |
Record Nr. | UNINA-9910459069203321 |
Washington, D.C., : National Academies Press, c2009 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Assessing and improving value in cancer care [[electronic resource] ] : workshop summary / / Adam Schickedanz, rapporteur ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
Pubbl/distr/stampa | Washington, D.C., : National Academies Press, c2009 |
Descrizione fisica | 1 online resource (165 p.) |
Disciplina | 616.994 |
Altri autori (Persone) | SchickedanzAdam |
Soggetto topico |
Cancer - Patients - Medical care
Cancer - Treatment - Economic aspects Cancer Neoplasms - therapy Neoplasms - economics Outcome Assessment, Health Care - economics |
Soggetto genere / forma | Congress. |
ISBN |
0-309-14733-6
1-282-43722-4 9786612437229 0-309-13815-9 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
""Front Matter""; ""Reviewers""; ""Contents""; ""Preface""; ""1 Introduction""; ""2 Opening Remarks: What Is Value in Cancer Care and Why Is It Important?""; ""PART I: Challenges to Value in Cancer Care""; ""3 Clinician Patient Communication and Its Influence on Value""; ""4 Generating Evidence About Effectiveness and Value""; ""5 Value and the Oncology Market""; ""6 Value in Oncology Practice: Oncologist and Health Insurer Perspectives""; ""7 Ethical Issues and Value in Oncology""; ""PART II:Solutions for Value in Cancer Care""; ""8 Improving Value in Oncology Practice: Ways Forward""
""9 Toward a Shared Understanding of Value""""Acronyms""; ""Glossary""; ""Appendix A: Workshop Agenda""; ""Appendix B: Speaker and Moderator Biographies"" |
Record Nr. | UNINA-9910792341503321 |
Washington, D.C., : National Academies Press, c2009 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Assessing and improving value in cancer care [[electronic resource] ] : workshop summary / / Adam Schickedanz, rapporteur ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Washington, D.C., : National Academies Press, c2009 |
Descrizione fisica | 1 online resource (165 p.) |
Disciplina | 616.994 |
Altri autori (Persone) | SchickedanzAdam |
Soggetto topico |
Cancer - Patients - Medical care
Cancer - Treatment - Economic aspects Cancer Neoplasms - therapy Neoplasms - economics Outcome Assessment, Health Care - economics |
Soggetto genere / forma | Congress. |
ISBN |
0-309-14733-6
1-282-43722-4 9786612437229 0-309-13815-9 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
""Front Matter""; ""Reviewers""; ""Contents""; ""Preface""; ""1 Introduction""; ""2 Opening Remarks: What Is Value in Cancer Care and Why Is It Important?""; ""PART I: Challenges to Value in Cancer Care""; ""3 Clinician Patient Communication and Its Influence on Value""; ""4 Generating Evidence About Effectiveness and Value""; ""5 Value and the Oncology Market""; ""6 Value in Oncology Practice: Oncologist and Health Insurer Perspectives""; ""7 Ethical Issues and Value in Oncology""; ""PART II:Solutions for Value in Cancer Care""; ""8 Improving Value in Oncology Practice: Ways Forward""
""9 Toward a Shared Understanding of Value""""Acronyms""; ""Glossary""; ""Appendix A: Workshop Agenda""; ""Appendix B: Speaker and Moderator Biographies"" |
Record Nr. | UNINA-9910823525103321 |
Washington, D.C., : National Academies Press, c2009 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The Bethesda handbook of clinical oncology / / editors, Jame Abraham, James L. Gulley |
Edizione | [Fifth edition.] |
Pubbl/distr/stampa | Philadelphia, Pennsylvania : , : Wolters Kluwer, , 2019 |
Descrizione fisica | 1 online resource (xiv, 807 pages) : illustrations |
Disciplina | 616.994025 |
Soggetto topico |
Cancer - Complications
Tumors - Treatment Tumors - therapy Neoplasms - therapy |
Soggetto genere / forma |
Electronic books.
Handbook |
ISBN | 1-4963-6716-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | 1. Head and neck cancer -- 2. Non-small cell lung cancer -- 3. Small cell lung cancer -- 4. Esophageal cancer -- 5. Gastric cancers -- 6. Biliary tract cancers -- 7. Primary cancers of the liver -- 8. Gastrointestional stromal tumors (GIST) -- 9. Colorectal cancer -- 10. Pancreatic cancer -- 11. Anal cancer -- 12. Breast cancer -- 13. Renal cell cancer -- 14. Prostate cancer -- 15. Bladder cancer -- 16. Testicular carcinoma -- 17. Ovarian cancer -- 18. Endometrial cancer -- 19. Cervical cancer -- 20. Vulvar cancer -- 21. Sarcomas and malignancies of the bone -- 22. Skin cancers and melanoma -- 23. Acute leukemia -- 24. Chronic lymphoid leukemias -- 25. Chronic myeloid leukemia -- 26. Chronic myeloproliferative neoplasms -- 27. Multiple myeloma -- 28. Non-Hodgkin lymphoma -- 29. Hodgkin lymphoma -- 30. Hematopoietic cell transplantation -- 31. Carcinoma of unknown primary -- 32. Central nervous system tumors -- 33. Endocrine tumors -- 34. Hematopoietic growth factors -- 35. Infectious complications in oncology -- 36. Oncologic emergencies and paraneoplastic syndromes -- 37. Psychopharmacologic management in oncology -- 38. Management of emesis --39. Medical nutrition therapy -- 40. Pain and palliative care -- 41. Central venous access device -- 42. Procedures in medical oncology -- 43. Basic principles of radiation oncology -- 44. Clinical genetics -- 45. Basic principles of immuno-oncoloy -- 46. Anticancer agents |
Record Nr. | UNINA-9910466456703321 |
Philadelphia, Pennsylvania : , : Wolters Kluwer, , 2019 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|